Level Biotechnology Inc. (TPEX:3118)
28.40
-0.50 (-1.73%)
Nov 20, 2026, 1:15 PM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 921.66 million as of November 20, 2026. It is the 33,885th most valuable company in the world and the 2,011th biggest in Taiwan. Its market cap has decreased by 15.22% in one year.
Market Cap
921.66M
Enterprise Value
727.53M
Revenue
695.30M
Global Rank
Country Rank
#2,011 Taiwan
PE Ratio
14.34
ChartMarket Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 921.66M, an increase of 269.13%. That is a compound annual growth rate of 6.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 921.66M | -13.94% |
| Dec 31, 2025 | 1.07B | 3.13% |
| Dec 31, 2024 | 1.04B | 5.09% |
| Dec 29, 2023 | 988.19M | 10.13% |
| Dec 30, 2022 | 897.32M | -7.68% |
| Dec 30, 2021 | 971.96M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.20B |
| Abnova (Taiwan) | 1.12B |
| LabTurbo Biotech | 1.04B |
| Bio Preventive Medicine | 996.39M |
| Enimmune | 967.26M |
| BiOptic | 893.39M |
| TCI GENE | 873.13M |
| Holy Stone Healthcare | 861.25M |